Parents of 12-Year-Old girl who died after taking COVID-19 vaccine file lawsuit against AstraZeneca

The parents of Karunya, a 20-year-old woman who tragically passed away after receiving the Covishield vaccine in July 2021, are pursuing legal action against Serum Institute of India (SII) and AstraZeneca, the vaccine's manufacturer and developer respectively.

Their decision to sue comes in light of AstraZeneca's admission in UK court documents that the vaccine can cause rare side effects, including blood clots and low platelet count. Seeking justice for their daughter's untimely death, the parents are urging a prompt investigation into the circumstances surrounding Karunya's demise and are demanding access to the findings.

Covishield, a product of collaboration between AstraZeneca and Oxford University, was manufactured by SII and extensively deployed in India during the pandemic. The vaccine, known globally under various brand names including Covishield and Vaxzevria, played a crucial role in vaccination efforts worldwide.

However, concerns have emerged regarding its potential side effects, prompting scrutiny and legal action from affected individuals and families like Karunya's parents, who are determined to uncover the truth behind their daughter's tragic fate.

As the legal battle unfolds, the case highlights the complexities and challenges surrounding vaccine safety and accountability. With ongoing investigations and mounting pressure for transparency, stakeholders are grappling with the need to address public concerns while ensuring the continued rollout of vaccines to combat the ongoing global health crisis.